Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-16042025-262467
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 1698]
NEW DELHI, WEDNESDAY, APRIL 16, 2025/CHAITRA 26, 1947
2541 GI/2025
MINISTRY OF FINANCE
(Department of Revenue)
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1729(E). — In exercise of the powers conferred by Sub-clause (b) of clause (xi) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares the following
substance, salt and preparations thereof to be manufactured drugs, namely:-
Butonitazene : N, N-Diethyl-2-[(4-butoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1730(E).— Whereas the Central Government is satisfied, on the basis of information and evidence which
has become available to it, with respect to the nature and effect of and the scope for abuse of the following substances
(natural or synthetic) or natural material or any salt or preparation of such substances or materials, and the modification
with respect to such substances and the changes that have been incorporated in the United Nations Convention on
Psychotropic Substances, 1971, that it is necessary to add the following substances or natural materials or salts or
preparation of such substances or materials in the list of psychotropic substances specified in the Schedule to the
Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) (hereinafter referred to as the said Act);
Now, therefore, in exercise of the powers conferred by section 3 of the said Act, the Central Government hereby
makes the following further amendments in the list of psychotropic substances specified in the Schedule to the said Act,
namely:-
In the said Act, in the Schedule, after serial number 110ZZE and the entries relating thereto, the following
serial numbers and entries shall respectively be inserted, namely :-
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
| S. No. | International non- | Other non-proprietary names | Chemical name |
| | proprietary names | | |
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
| "110ZZF | | 3-Chloromethcathinone (3-CMC)| 1-(3-chlorophenyl)-2- (methylamino)propan-1-one |
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
| 110ZZG | | Dipentylone | 1-(1,3-benzodioxol-5-yl)-2- (dimethylamino)pentan-1-one |
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
| 110ZZH | | 2-Fluorodeschloroketamine | 2-(2-fluorophenyl)-2- (methylamino)cyclohexan-1-one) |
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
| 110ZZI | | Bromazolam | Bromo-1-methyl-6-phenyl-4H-s- triazolo[4,3-a][1,4]benzodiazepine|
+---------+---------------------------------------------+------------------------------+---------------------------------------------------------+
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
Note: The Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) was first amended, vide
number S.O. 785(E), dated the 26th October, 1992 and subsequently amended, vide numbers S.O. 49(E), dated
the 8th January, 1993, S.O. 39(E), dated the 12th January, 1996, S.O. 475(E), dated the 11th June, 2003,
G.S.R. 621(E), dated the 1st August, 2003, G.S.R. 1(E), dated the 2nd January, 2004, S.O. 311 (E), dated the
10th February, 2011, S.O. 376(E), dated the 5th February, 2015, S.O. No. 2374 (E), dated the 12th July, 2016,
S.O. No. 1383 (E), dated the 2nd May, 2017, S.O. 821(E), dated the 27th February, 2018, S.O. 1761(E), dated the
26th April, 2018 and S.O. 3448(E) dated the 13th July, 2018, S.O. 1352(E), dated the 13th March 2019,
S.O. 1275(E), dated the 23rd March 2021, S.O. 4428(E), dated the 22nd September 2022, S.O. 5319 (E), dated
the 16th November, 2022 and S.O. 578(E), dated the 8th February, 2024.
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1731(E). — In exercise of the powers conferred by clause (viia) and (xxiia) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby makes the following further
amendments in the notification of the Government of India, Ministry of Finance, Department of Revenue, published in
the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 1055 (E), dated the 19th October,
2001, namely:-
In the said notifications, in the Table, after serial number 238 ZZZG and the entries relating thereto, the
following serial numbers and entries shall respectively be inserted, namely: -
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
| S. No. | Name of | Other non-proprietary names | Chemical name | Small Quantity (in | Commercial Quantity |
| | Narcotic Drug and | | | gm.) (Single | (in gm.) |
| | Psychotropic Substance | | | dose in gm | (Small |
| | (International non- proprietary names (INN)) | | | X 100) | quantity in gm X 50) |
+===========+==============================================================+==============================+=========================================================+===============================================+=================================================+
| "238ZZZH | Butonitazene | | N,N-Diethyl-2- [(4-butoxyphenyl)methyl]- 5-nitro- 1H- | 5gm | 250gm |
| | | | benzimidazole-1- ethanamine | | |
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
| 238ZZZI | | 3-Chloromethcathinone (3-CMC)| 1-(3-chlorophenyl)- 2-(methylamino)propan- 1-one | 5 gm | 250gm |
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
| 238ZZZJ | | Dipentylone | 1-(1,3-benzodioxol-5-yl)- 2-(dimethylamino)pentan- 1-one| 2 gm | 100 gm |
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
| 238ZZZK | | 2- Fluorodeschloroketamine | 2-(2-fluorophenyl)-2- (methylamino)cyclohexan- 1-one) | 5 gm | 250 gm |
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
| 238ZZZL | | Bromazolam | Bromo-1-methyl-6- phenyl-4H-s-triazolo[4,3- a][1,4]benzodiazepine| 0.1 gm | 5 gm |
+-----------+--------------------------------------------------------------+------------------------------+---------------------------------------------------------+-----------------------------------------------+-------------------------------------------------+
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
Note: The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section
(ii), vide number S.O. 1055 (E), dated the 19th October, 2001 and subsequently amended vide numbers
S.O. 2941 (E), dated the 18th November, 2009, S.O. 1430 (E), dated the 21st June, 2011, S.O. 375 (E) dated the
5th February, 2015, S.O. 2375(E), dated the 12th July, 2016, S.O. 384 (E), dated the 2nd May, 2017, S.O. 822(E),
dated the 27th February, 2018, S.O. 1762(E), dated the 26th April, 2018, S.O. 1351 (E), dated the 13th March
2019, S.O. 1276 (E), dated the 23rd March 2021, S.O. 4429 (E), dated the 22nd September 2022, S.O. 5320 (E),
dated 16th November, 2022 and S.O. 578(E), dated the 8th February, 2024.